|
2002/2003 Research Operating Funds |
|
2002/2003 Research Operating Funds |
| INVESTIGATORS | AGENCY | YEAR |
| Brian Gilfix | Dr. Louis G. Johnson Foundation Grant (Investigator) | 2002 |
| Valerie Désilets | Canadian Institute for Health Research (Co-investigator) Male Mediated Developmental Toxicity: Chemotherapy, Sperm Chromatin, Psychosocial and Progeny Outcome | 2003 - 2008 |
| Montreal Children's Hospital Foundation (Co-investigator) Isolation of fetal free DNA in maternal serum to evaluate CFTR gene mutations in fetuses at risk for cystic fibrosis. | 2003 - 2004 |
|
| FRSQ (Co-investigator) Groupe de recherche Groupe de recherche en diagnostic prénatal. Etablissement d'une banque de données | 2001 - 2003 | |
| FRSQ (Co-investigator)
Suivi prospectif des nouveaux-nés avec hernie diaphragmatique congénitale. |
||
| Ken Dewar | Genome Canada/Genome Quebec Large-scale project: Regulatory Genetics – High throughput screening of gene targets related to common genetic diseases. | 2001 - 2005 |
| Eleanor Elstein | Medical Research Council of Canada
|
2000 - 2002 |
| William Foulkes | US Army (PI) Locating a prostate cancer susceptibility gene on the X chromosome by linkage disequilibrium mapping using three founder populations in Quebec and Switzerland. | 1999 - 2002 |
| Cancer Research Society-Canada (PI). Towards a molecular description of Proteus syndrome. | 2001 - 2003 |
|
| US Army (PI) Is breast tissue from women who carry germ-line BRCA1 or BRCA2 mutations abnormal? An immunohistochemical study. | 2001 - 2002 |
|
| NIH- U S A
Prostate Cancer Susceptibility: The ICPCG Study. |
2002 - 2006 | |
| Valorisation Recherche Québec VRQ/FRSQ
(Co-Investigator) Banque de tissus et de données pour le cancer du sein et du l'ovaire. |
2002 - 2006 | |
| Canadian Institute for Health Research
(Co-Investigator) Programme de recherche en appui aux politiques de santé en génétique dans un souci de qualité, d’efficience et de bien-être social. |
2003 - 2007 | |
| US Army (PI)
Identifying early events in BRCA2-related breast cancer using isogenic cell lines. |
2003 - 2004 | |
| Thomas Hudson | Canadian Foundation for Innovation (PI)
Expansion of genomics and proteomics infrastructure in Quebec |
2002 - 2006 |
| Genome Canada/Genome Quebec (PI)
Large-scale project: A Haplotype Map of the Human Genome-Biomedical Tool for Genetic Research in Canada. |
2002 - 2005 | |
| Canadian Institutes of Health Research
(clinical investigations) Genetic and Environmental Factors in Systemic Lupus Erythematosus. Focus on chromosome 1, apoptosis, and the environment. |
2002 - 2007 | |
| Canadian Institute of Health Research
Operating grant Selection and Validation of Target Genes Implicated in the Clinical and Biological Features of Ovarian Cancer |
2002 - 2005 | |
| Juvenile Diabetes Foundation International
A function-driven, large scale approach to the search for type-1 diabetes susceptibility genes. |
2001 - 2006 |
|
| Genome Canada/Genome Quebec (PI)
Large-scale project: Regulatory Genetics – High throughput screening of gene targets related to common genetic diseases. |
2001 - 2005 | |
| Genome Canada/Genome Quebec (PI)
Expertise Centre: The Montreal Genomics Node of Excellence. |
2001 - 2005 | |
| Genome Canada/Genome Quebec (Co-investigator)
Large-scale project: Atlas of Genomics Profiles of Steroid Action. |
2001 - 2005 | |
| Canadian Institutes of Health Research (PI)
Genetic Analysis in Canadian Populations |
2001 - 2006 |
|
| Valorisation-Recherche Québec
Plateformes structurantes du réseau cancer du FRSQ : modélisation, services d’analyses et banques de tissus et de données |
2002 - 2006 | |
| Burroughs Wellcome Fund (PI)
Genomic approaches to identify genes predisposing to asthma |
2002 - 2007 | |
| Fonds de la recherche en santé du Québec
Projet Cart@gne - Développement de puces a AND a haut débit Réseau de Médecine Génétique Appliquée |
2001 - 2004 | |
| Canadian Institute of Health Research
Operating grant ARSACS: Understanding the Disease |
2001 - 2006 | |
| Canadian Institutes of Health Research
Ecogene-21: An alliance for research in community genetics Community Allianceses for Health Research |
2001 - 2005 | |
| Multiple Sclerosis Foundation
Program Grant Myelin Gene Regulation: A Multidisciplinary approach |
2000 - 2003 | |
| Montreal Breast Cancer Foundation
Expression chips and breast cancer. Why do women get breast cancer? Clues for the prevention of breast cancer from an understanding of predisposition. |
2000 - 2003 | |
| Fonds de la recherche en santé du Québec
Axe cancer du sein et de l’ovaire : Réseau de banques de tissus et de données Réseau Cancer |
2000 - 2003 | |
| Canada Foundation for Innovation and matching
funds from Government of Quebec, Biochem Pharma, PE Applied Biosystems & Fisher Scientific Regional/national facility program (PI) Montreal Genome Centre |
1999 - 2003 | |
| Networks of Centres of Excellence –
Phase III (PI)
Genotyping core facility Canadian Genetic Diseases Network [CGDN] |
1998 - 2005 | |
| Networks of Centres of Excellence –
Phase III (PI)
Expression studies using high-density arrays Canadian Genetic Diseases Network [CGDN] |
1998 - 2005 | |
| Kenneth Morgan | Networks of Centres of Excellence
(Investigator) Group Grant Canadian Genetic Diseases Network - Phase III: From genes to therapies |
1990 - 2005 |
| Networks of Centres of Excellence
(Investigator) Group Grant The Mathematics of Information Technology and Complex Systems. |
1999 - 2005 | |
| Canadian Institute Health Research
(Investigator) Strategic training program grant Training centre in integrative biology of infectious diseases and autoimmunity. |
2003 - 2008 |
|
| Canada Foundation for Innovation
(Investigator) Infrastructure Montreal Genome Centre (04/1999 - 06/2003). |
1999 - 2003 | |
| Genome Canada/Genome Quebec (Investigator)
Genome Quebec Genomic Centre; Large-Scale Project: Regulatory Genetics - high throughput screening of gene targets related to common genetic diseases |
2001 - 2005 | |
| Genome Canada/Genome Quebec (Investigator)
Genome Quebec Genomic Centre; Expertise Centre: The Montreal Genomics Node of Excellence |
2001-2005 | |
| David Rosenblatt | March of Dimes (PI)
Identification of genes for cobalamin-dependent homocysteine remethylation. |
2001 - 2004 |
| Canadian Institute Health Research
Inborn errors of cobalamin and folate metabolism. |
2001 - 2005 | |
| Garrod Association
Molecular analysis of patients with classical and atypical methylmalonic aciduria. |
2001 - 2002 |
|
| Guy Rouleau | Canadian Institute Health Research
Characterizing the gene for peripheral neuropathy agenesis of corpus callosum callosum. |
2002 - 2007 |
| Canadian Institute Health Research
Molecular Genetic Investigation of Oculopharyngeal Muscular Dystrophy. |
2002 - 2007 | |
| MDA US
Identification of a new gene for autosomal dominant familial amyotrophic lateral sclerosis. |
2002 - 2004 | |
| Patricia Tonin | FRSQ: Reseau cancerologie
Operating - Group Banque de tissues et de données pour le cancer du sein et du l’ovaire. |
2000 - 2005 |
| Canadian Foundation for Innovation
(Investigator)
Host Institution: Université de Montréal - Infrastructure - Innovation Fund Reseau de banques de tissus et de donneés pour le cancer du sein et de l’ovaire |
2000 - 2004 | |
| Valorisation-Recherche Québec (VRQ)
(Investigator) Operating - Group Banque de tissues et de données pour le cancer du sein et du l’ovaire. |
2002 - 2006 | |
| Canadian Foundation for Innovation
(Investigator)
Infrastructure - Innovation Fund Expansion of genomics and proteomics infrastructure in Québec. |
2002 - 2006 | |
| Canadian Institutes of Health Research
Operating Identification of tumor suppressors in epithelial ovarian cancer. |
2002 - 2005 | |
| Genome Canada & Génome Québec
(Investigator)
Operating - Group - Large-scale Projects Integrative Genomics for Women’s Health program (IGWH). |
2002 - 2005 | |
| Canadian Institute of Health Research
(Collaborator) Selection and validation of target genes implicated in the clinical and biological features of ovarian cancer. |
2002 - 2005 | |
| Canadian Institute of Health Research
(Investigator) Infrastructure (for the purchase of Celera Genome Database) Celera Genome Database. |
2002 - 2005 | |
| Cancer Research Society, Inc. (Investigator)
Characterization of breast cancer families of French Canadian descent: A genetic analysis of a founder population in the search of a novel breast cancer susceptibility gene. |
2002 - 2004 | |
| Cancer Research Society, Inc. (Investigator)
Strategic Grant A model for modulating genetic and epigenetic events that influence the metastatic potential of ovarian cancer. |
2002 - 2004 |
|
| Montreal Breast Cancer Foundation
(Investigator)
Group-operating New modalities for breast cancer diagnosis and treatment. |
2003 - 2006 | |
Members
| Report | Meetings
Publications | Funds
| Financials
© 2003 Finestone Laboratory
